Skip to content
DraconiticResearch
Search Sources API
190,335 studies31 sourcesUpdated 13 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Advances in Research on Panax Ginseng-Derived EV-like Particles

  1. 1Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun 130117, China

Abstract

Panax ginseng-derived EV-like particles (PG-EVLPs) are nanoscale lipid bilayer vesicles extracted from ginseng roots, stems, leaves, or cell cultures, with diameters typically between 50 and 200 nm. Available preclinical studies have demonstrated that PG-EVLPs exhibit favorable in vitro and in vivo biocompatibility and short-term safety, without obvious hemolysis, cytotoxicity or organ damage, making them an active area of research at the intersection of traditional Chinese medicine and nanomedicine. This review covers separation and purification methods, physicochemical characterization techniques, bioactive component composition, and pharmacological mechanisms of PG-EVLPs. It also evaluates several delivery strategies, including natural nanocarrier delivery, engineering modification, and hydrogel composite systems, and discusses current challenges in standardization, safety assessment, and clinical translation.

Related

  1. Elucidation of Selective Apoptosis of Breast Cancer Cells Induced by Panax ginseng-Derived Exosomes via Regulation of Bax/Bcl-2 Ratio and AMPK-α Signaling.
    Min Ho Han, Youn Seon Hwang, Jong Hyun Oh +3
    International journal of breast cancerPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  2. Panax ginseng Across the Cardiovascular Continuum: Molecular Targets, Mechanistic Convergence, and Translational Challenges
    Min Qiao, Chang Sun, Yangyang Qin +5
    BiomoleculesPeer-reviewedCC BY 4.0General biochemistryCrossref
  3. Panax ginseng in psychiatric disorders: Mechanisms and therapeutic potentials.
    Hye Ji Choi, Young Min Choe, Ji-Hyun Kim +7
    Journal of ginseng researchPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMCPMC
  4. Light Intensity and Gibberellic Acid Differentially Shape Primary Metabolism and Ginsenoside Profiles in Panax ginseng Sprouts
    Seonghye Kim, Bo-Ram Choi, Hyeon Seon Na +7
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  5. Temporal Dynamics and Regulatory Control of Ginsenoside Accumulation During Leaf Senescence in Panax ginseng.
    Heng Wei, Wenhao Jia, Junbo Rong +5
    Plants (Basel, Switzerland)Peer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
BibTeX
@article{yan2026advances,
  title = {{Advances in Research on Panax Ginseng-Derived EV-like Particles}},
  author = {Qi Yan and Tianxia Sun and Enpeng Wang},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = sep,
  doi = {10.3390/ijms27188320},
  url = {https://www.mdpi.com/1422-0067/27/18/8320},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Advances in Research on Panax Ginseng-Derived EV-like Particles
AU  - Qi Yan
AU  - Tianxia Sun
AU  - Enpeng Wang
PY  - 2026
DA  - 2026/09/18
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27188320
UR  - https://www.mdpi.com/1422-0067/27/18/8320
AB  - Panax ginseng-derived EV-like particles (PG-EVLPs) are nanoscale lipid bilayer vesicles extracted from ginseng roots, stems, leaves, or cell cultures, with diameters typically between 50 and 200 nm. Available preclinical studies have demonstrated that PG-EVLPs exhibit favorable in vitro and in vivo biocompatibility and short-term safety, without obvious hemolysis, cytotoxicity or organ damage, making them an active area of research at the intersection of traditional Chinese medicine and nanomedicine. This review covers separation and purification methods, physicochemical characterization techniques, bioactive component composition, and pharmacological mechanisms of PG-EVLPs. It also evaluates several delivery strategies, including natural nanocarrier delivery, engineering modification, and hydrogel composite systems, and discusses current challenges in standardization, safety assessment, and clinical translation.
SN  - 1422-0067
ER  -